Company intelligence / Profile preview

Pathway OME

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Pathway OME (Pathway Genomics OME) operates a commercial DNA testing and reporting platform, including tests such as Sport iQ that analyze genetic variants related to exercise performance and wellness; it offers interpretation and recommendations but does not sponsor drug clinical trials.[3]

Therapeutic areas: OtherMetabolic Disorders
Modalities: Non-pharmacological therapyDevice
Industry: Molecular Diagnostics

Partnerships

IBM Watson (AI/precision medicine collaboration, at the Pathway Genomics corporate level)[1][2]

Beyond the preview

Go deeper on Pathway OME.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathway OME.

Explore the full profile